Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.71 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.71 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.71 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.71 |
| ▸ | CA12 | O43570 | 1/20 | 0.71 |
| ▸ | CA2 | P00918 | 1/20 | 0.71 |
| ▸ | CA4 | P22748 | 1/20 | 0.71 |
| ▸ | PPARG | P37231 | 1/20 | 0.71 |
| ▸ | CA7 | P43166 | 1/20 | 0.71 |
| ▸ | XDH | P47989 | 1/20 | 0.71 |
| ▸ | IPMK | Q8NFU5 | 1/20 | 0.71 |
| ▸ | IP6K2 | Q9UHH9 | 1/20 | 0.71 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.68 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.66 |
| ▸ | TUBB | P07437 | 1/20 | 0.66 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.66 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.66 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.66 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3642770 | 0.94 | TUBB4A (0.69) | MEN1KMT2ACYP1A1CYP1A2CYP1B1 | |
| SCHEMBL3727374 | 0.92 | TUBB4A (0.80) | MEN1KMT2ACYP1A1CYP1A2CYP1B1 | |
| SCHEMBL3735023 | 0.90 | MEN1 (0.68) | MEN1KMT2ACYP1A1CYP1A2CYP1B1 | |
| Potassium Ion SCHEMBL29466606 | 0.90 | MEN1 (0.68) | MEN1KMT2ACYP1A1CYP1A2CYP1B1 | |
| 3,3'-O-Dimethylquercetin SCHEMBL1252850 | 0.89 | ABCG2 (0.84) | MEN1KMT2ACYP1A1CYP1A2CYP1B1 | |
| 3,3'-O-Dimethylquercetin SCHEMBL29443769 | 0.89 | ABCG2 (0.84) | MEN1KMT2ACYP1A1CYP1A2CYP1B1 | |
| 3,3'-O-Dimethylquercetin SCHEMBL25243901 | 0.88 | ABCG2 (0.83) | MEN1KMT2ACYP1A1CYP1A2CYP1B1 | |
| SCHEMBL3403244 | 0.88 | POLH (0.72) | MEN1KMT2ACYP1A1CYP1A2CYP1B1 | |
| SCHEMBL29897597 | 0.88 | POLH (0.72) | MEN1KMT2ACYP1A1CYP1A2CYP1B1 | |
| SCHEMBL8015255 | 0.86 | TUBB4A (0.67) | MEN1KMT2ACYP1A1CYP1A2CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100279961-A1 | PHARMACEUTICAL COMPOSITION HAVING A TRIHYDROXY-CHROMENONE DERIVATIVE | ANALYTICON DISCOVERY GMBH (DE) | 2010-11-04 | — | — | US | claimed |
| US-20190085007-A1 | 4-methylcatechol Derivatives and Uses Thereof | Thanares GmbH (DE) | 2019-03-21 | — | — | US | disclosed |
| US-20160347782-A1 | 4-methylcatechol Derivatives and Uses Thereof | Thanares GmbH (DE) | 2016-12-01 | — | — | US | disclosed |
| US-20100279961-A1 | PHARMACEUTICAL COMPOSITION HAVING A TRIHYDROXY-CHROMENONE DERIVATIVE | ANALYTICON DISCOVERY GMBH (DE) | 2010-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100279961-A1 | PHARMACEUTICAL COMPOSITION HAVING A TRIHYDROXY-CHROMENONE DERIVATIVE | UGT2B17, UGT1A3, UGT1A4 | MEN1 2912/4885KMT2A 4018/4885CYP1A1 80/4885 |
| US-20190085007-A1 | 4-methylcatechol Derivatives and Uses Thereof | ST3GAL3, GALE, DPP4 | MEN1 2681/4885KMT2A 454/4885CYP1A1 360/4885 |
| US-20160347782-A1 | 4-methylcatechol Derivatives and Uses Thereof | ST3GAL3, GALE, DPP4 | MEN1 2681/4885KMT2A 454/4885CYP1A1 360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.